3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Melanoma
312
Carcinoma, Basal Cell
60
Skin Neoplasms
53
Lymphoma, T-Cell, Cutaneous
37
Breast Neoplasms
31
Uveal Melanoma
29
Neoplasms
27
Lung Neoplasms
27
Carcinoma, Non-Small-Cell Lung
27
Keratosis, Actinic
25
Neoplasm Metastasis
24
Carcinoma, Squamous Cell
22
Carcinoma, Renal Cell
21
Lymphoma
17
Mycosis Fungoides
16
Lymphoma, Large B-Cell, Diffuse
15
Hodgkin Disease
15
Urinary Bladder Neoplasms
14
Sezary Syndrome
14
Pancreatic Neoplasms
14
Lymphoma, Non-Hodgkin
14
Lymphoma, Follicular
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Ovarian Neoplasms
13
Lymphoma, Mantle-Cell
13
Lymphoma, B-Cell, Marginal Zone
13
Colorectal Neoplasms
13
Burkitt Lymphoma
13
Lymphoma, Large-Cell, Immunoblastic
12
Interventions
salicylhydroxamic acid
1
Triamcinolone Acetonide
1
Ranibizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Retinal Diseases
×
Dermatologic
×
Clear all
NCT00811200
2009-07-02
TORR
Leiden University Medical Center
Phase 2/3
Unknown
220 enrolled